Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus. - Wikidata - awgldk - TriplyDB

Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus.

Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus.

http://www.wikidata.org/entity/Q36892489

about

The Emerging Role of Disturbed CoQ Metabolism in Nonalcoholic Fatty Liver Disease Development and Progression Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies.Endothelial PGC-1α mediates vascular dysfunction in diabetes.Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment.Fiber-rich diet with brown rice improves endothelial function in type 2 diabetes mellitus: A randomized controlled trial.Nutraceuticals and headache: the biological basis.Irisin promotes human umbilical vein endothelial cell proliferation through the ERK signaling pathway and partly suppresses high glucose-induced apoptosis.Acute effect of phosphodiesterase type 5 inhibitor on serum oxidative status and prolidase activities in men with erectile dysfunction.Therapeutic Effects of PPAR α on Neuronal Death and Microvascular Impairment.Antioxidant diet and sex interact to regulate NOS isoform expression and glomerular mesangium proliferation in Zucker diabetic rat kidney.Hyperglycemia, diabetes and stroke: focus on the cerebrovasculature.Feed-forward signaling of TNF-alpha and NF-kappaB via IKK-beta pathway contributes to insulin resistance and coronary arteriolar dysfunction in type 2 diabetic mice Protective effects of antioxidant-fortified diet on renal function and metabolic profile in obese Zucker rat.Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in men with diabetes mellitus Reversibility of endothelial dysfunction in diabetes: role of polyphenols.Antioxidants and diabetes.Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy.The gastrointestinal peptide obestatin induces vascular relaxation via specific activation of endothelium-dependent NO signalling.Anti-ischaemic activity of an antioxidant aldose reductase inhibitor on diabetic and non-diabetic rat hearts.Assessment of the acute effects of tadalafil on the cardiovascular system based on examination of serum oxidative status and paraoxonase activity in men with erectile dysfunction: a preliminary study.In vivo regulation of endothelium-dependent vasodilation in the rat renal circulation and the effect of streptozotocin-induced diabetes.Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission.Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment.Endothelial dysfunction in patients with type 2 diabetes post acute coronary syndrome.

P2860

Q26775025-98B730B4-E41A-43F3-B7CE-D5E7DE080ECB Q33649275-FD2DCA6C-669C-4EC1-ACC6-92BFEDD55C83 Q33692952-22C2022C-08B1-4B4B-B703-CFB1DED33AD5 Q33776230-D64435DD-48F1-45A0-9068-ECEDBA0F2345 Q33853108-F684AE39-835D-4EBD-ADCF-B9FCB57A9133 Q34166931-41FF62E3-7CB0-412C-BDA2-14F95AE6512D Q34387468-DFFD9004-0771-4E1B-BE0E-F9F95F7B4E13 Q34487002-0EB9FEE4-7652-4DD3-9928-0F12EFA20428 Q35078274-6036F6F9-ACAD-464E-A059-A04D8F467134 Q36586114-13D17251-BA13-4C13-8B57-A838F7B257FF Q37067129-2601FD4F-A168-4671-BECD-D03C9B6C2985 Q37276227-297CAB30-0673-4043-8C7D-B113942B45B8 Q37434847-1405BA8A-D99B-4BC4-87D5-7EEE2841F77C Q38466768-38900D9C-BCC8-4183-A6BD-911D8A7330A5 Q38855635-214A7411-53E8-4FE5-A138-634F6CC4E788 Q39438438-D38051C9-9C44-4CA5-8182-66943E54F45D Q41763148-F4F6E8CE-27EB-4CDC-B3B2-6C67B1C2D4A5 Q42073661-62C42811-6C13-4499-8E83-C2767E1DEDEF Q42932522-6674B1C5-6033-49A3-BFD9-A6099E47A059 Q43221805-3AF29440-93A4-4F4B-B9AA-F66E0BE550B1 Q46477821-F87F0837-AA7C-466E-B10A-287623A840BC Q47201817-20435359-4254-4FFF-B3C7-611D0DDE27BD Q47557757-900FECC1-9982-4858-8BD7-72BF8C17BB18 Q50994556-F0FDD358-4DA4-499E-B215-A7315912450D

P2860

Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus.

http://www.wikidata.org/entity/Q36892489

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus.

@en

type

label

Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus.

@en

prefLabel

Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus.

@en

P1433

Q36892489-7CA867DE-D79A-45D0-9357-87F2BE2F3183

P1476

Q36892489-6CEA9068-FFD7-44EE-8829-785852510B17

P2093

Q36892489-6C9875F3-5EAC-40C4-9B0F-38EF647095CE

P2860

Q36892489-00AB3282-46A4-4B65-BB17-86E3B6185519

Q36892489-00AE3591-95F0-4CB8-BA5F-7DB97B78A3CE

Q36892489-03FD8AEC-0679-420E-9E01-08D12CB8219F

Q36892489-04466381-AA24-4229-8EB0-4061BF99E01B

Q36892489-05D94FDA-90DC-47E4-982D-20005B2AA207

Q36892489-08D9D489-5186-4862-9D12-99738DF560AD

Q36892489-08DF16F3-A718-4E9E-8481-525151C39F53

Q36892489-0C785E8B-4524-44AF-B57D-5C328193D2B3

Q36892489-0D97CFBC-7C89-480A-9C74-83CAB861FF7E

Q36892489-0DF4A99F-D103-4B4A-AD4F-5FBFC48D1C5D

P304

Q36892489-B97D44CA-405F-4900-BD1A-3284716B16F8

P31

Q36892489-DD1E4DD2-CC61-4CD7-AB94-EF82A159BBEE

P356

Q36892489-DCF9DADB-F1AC-4A7B-8957-E0D1AB14BCE4

P407

Q36892489-040C5318-FA92-4076-81F7-BB608598EB09

P433

Q36892489-ED4EF6FD-6B4B-479E-A4C8-07D050D949A5

P478

Q36892489-9BDE89ED-1170-4FF8-AEAA-1754893EED89

P50

Q36892489-4BF1CCBC-29DB-46B8-9ACE-29EEF1575D72

Q36892489-C1D926B8-2052-439D-A68B-08AA4EA7F2F5

P577

Q36892489-62CAD28D-5594-4814-AD0B-C17A47489525

P5875

Q36892489-2B3D762B-7A2B-407C-8936-48C953BBB1AE

P698

Q36892489-D4705520-210F-422F-8805-635F317290F3

P921

Q36892489-1226620D-7B39-4BF3-A0DF-C0CE4990EDCE

Q36892489-CFB74E68-0D6A-4B37-A816-CE979C018B4E

P356

P1433

Diabetes and Vascular Disease Research

P1476

Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus

@en

P2093

Gerard T Chew

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease

Endothelial dysfunction: a comprehensive appraisal.

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria.

Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome.

The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial.

The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes.

Lipids and the endothelium.

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

P304

89-102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3132/DVDR.2007.026

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Sandra J Hamilton

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6185236

http://www.w3.org/2001/XMLSchema#string

P698

17654442

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes